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Purpose: To investigate retinal changes prior to vascular signs in patients with type 2 diabetes without diabetic
retinopathy or with mild non proliferative diabetic retinopathy.
Methods: A cross-sectional study was performed in three groups: patients without diabetes, patients with type 2
diabetes without diabetic retinopathy, and patients with diabetes with mild diabetic retinopathy. Analysis of retinal
layers was performed objectively with the Cirrus Review Software 6.0 (Carl Zeiss Meditec, Dublin, CA, USA). Macular
cube scans were analyzed with regard to: the ganglion cell layer + inner plexiform layer analysis, retinal nerve fiber
layer thickness, central subfoveal retinal thickness and average macular thickness.
Results: In total, 102 patients were included in this study, of which 28 (27.4%) were classified into control group,
46 (45.0%) classified as diabetic patients with no diabetic retinopathy and 28 (27.4%) classified as mild diabetic
retinopathy. Quantitative analysis with the Cirrus software showed that the mean ganglion cell layer and mean
retinal nerve fiber layer were thinner in diabetes without diabetic retinopathy group when compared to controls.
ANOVA with Bonferroni post test indicated a statistically significant reduction in average retinal thickness in mild
diabetic retinopathy group (P = 0.032) compared to control and reduction in ganglion cell layer in diabetes with
no diabetic retinopathy (P = 0.039) and mild diabetic retinopathy (P = 0.003). Also indicated reduction in retinal
nerve fiber layer in diabetic without diabetic retinopathy and eyes with mild diabetic retinopathy (P < 0.001),
compared to controls.
Conclusions: Our study found reduction in thickness of ganglion cell layer and retinal nerve fiber layer in patients
with diabetes without diabetic retinopathy, which suggests neuroretinal changes before vascular signs of diabetic
retinopathy.
Keywords: Diabetes mellitus, Diabetic retinopathy, OCT, Optical coherence tomography, Macula, Retina, Neuronal,
NeurodegenerationBackground
Diabetic retinopathy (DR) is considered one of the main
causes of blindness in patients between 30 and 60 years old
in the Western world. Despite recent progress, current
treatment with pharmacologic and laser treatment may not
be enough in some patients to prevent blindness. DR has
been considered mostly a vascular disease, but recent inves-
tigations have demonstrated degenerative and neuronal* Correspondence: rodriguesretina@gmail.com
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unless otherwise stated.alterations before the appearance of microvascular changes
in patients with diabetes mellitus (DM) [1,2]. Animal and
human studies support the presence of neuronal alterations
including apoptosis in early stages of diabetes [3-6].
Optical coherence tomography (OCT) enables deep
comprehension of a variety of eye diseases [7,8]. Newer
generation spectral domain OCT allows detailed examin-
ation of retinal cells and vessels, thereby facilitating the
study of disease pathogenesis. Clinically, different authors
have reported decrease in total central retinal or single
cellular layer thickness in diabetic eyes with or withoutral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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with no DM) [1,2]. Others have shown reduction in the
inner retinal thickness in the macula in diabetics with mild
DR, which may represent initial ganglion cell loss in the
pericentral areas followed by retinal nerve fiber layer (RNFL)
thinning in the peripheral macula [5,6,9].
The goal of this study was to investigate retinal changes
prior to vascular signs in patients with type 2 diabetes
without diabetic retinopathy or with mild non proliferative
diabetic retinopathy.
Methods
A cross-sectional study was performed with enrollment of
three groups: (A) control patients without diabetes; (B) pa-
tients with type 2 diabetes with no clinical or angiographic-
ally diagnosed DR, and (C) patients with type 2 diabetes
mellitus with mild DR. Patients were examined in the De-
partment of Ophthalmology at the Federal University of São
Paulo after IRB approval, and signed informed consent to
comply with voluntary participation in this research project.
The institution “Comitê de Ética da Universidade Federal de
São Paulo” approved this research project. Experiments were
conducted according to Declaration of Helsinki.
Control subjects did not have a diagnosis of diabetes, any
ocular disease, or any other systemic disease. These subjects
were randomly recruited from individuals accompanying pa-
tients visiting the Department of Ophthalmology.
The inclusion criteria was individuals with type 2 DM and
above the age of 40 years. The choice of type 2 diabetes was
due to its prevalence and importance of future projection.
Mild DR was considered as the presence of at least one
microaneurysm in the retina, but no other diabetic lesions -
according to the classification of the international clinical
diabetic retinopathy disease severity scale [9]. Patients were
excluded from the study if they presented with a best cor-
rected visual acuity less than 20/25, when OCT images
were of inadequate quality (sinal strength below 7), if DR
equal or worse than moderate, lens opacity and other vision
impairing diseases such as glaucoma, cataract, uveitis, or
macular degeneration.
All patients underwent clinical examination with review






Age, years* 54 ± 10 59 ±
Gender, male:female 14:14 17:2
Glycemia, mg/dL* 92.50 ± 9.19 167
HbA1c, % - 7.55
Duration of DM, years - 12 ±
The values are mean SD for all subjects in each group. “-”: not done. *Statistically sitime of diabetes, last glucose, last glycosylated hemoglobin
(HbA1c), systemic hypertension (yes or no), nephropathy
(yes or no), best corrected visual acuity. Patients were evalu-
ated with respect to best corrected visual acuity using the
Snellen chart. The patients had pupil dilation by tropicamide
and evaluation through digital color fundus photography,
fluorescein angiography (FA) and spectral-domain optical
coherence tomography (SD-OCT) (Cirrus ™ HD-OCT 4000,
Carl Zeiss Meditec, Dublin, CA, USA). FA and SD-OCT
were performed in the mornings.
FA examination was used as a screening to verify angiog-
raphy criteria and was performed by a different examiner
from the OCT images. Retina specialists who analyzed OCT
images neither took part in the screening, nor they were
aware details about individuals of the screening.
Only SD-OCT analysis of right eye was performed,
centered on the fovea and repeated three times by the
examiner. Only scans with signal strengths ≥7 and without
artifact were included in the study. The acquisition proto-
cols were as follows: macular cube 200 × 200; HD 5 line
raster/5 raster line; and HD one line. The raw OCT data-
sets were exported to a personal computer for analysis.
Analysis of retinal layers of the right eye was performed
using specific software, Cirrus HD-OCT Review Software
6.0 (Carl Zeiss Meditec, Dublin, CA, USA). The software,
patented by Carl Zeiss Meditec, measured the various ret-
inal layers in order to produce data for further analysis.
Two types of measurements were performed: automated
and subjective (by software caliper).
Macular cube scan generated the following automated
data: ganglion cell layer + inner plexiform layer (GCL +
IPL) thickness, RNFL thickness, central subfoveal retinal
thickness (CS), and average retinal thickness (RT). Aver-
age thicknesses of eight areas were examined for each
scan, determined by ETDRS grid: nasal, superior, tem-
poral, inferior, nasal superior, nasal inferior, temporal su-
perior and temporal inferior.
Line scans were performed in order to proceed the sub-
jective analysis, only. Line scans used were centered on
fovea, with a 0° angle. The subjective analysis was performed
by two independent retina specialists, who have not taken





10 62 ± 11 0.01
9 11:17 0.53
.33 ± 134.44 148.81 ± 70.72 0.01
± 1.57 7.16 ± 1.22 0.10
7 12 ± 9 0.98
gnificant difference between mild DR and controls (P <0.05).
Figure 1 Boxplot shows mean ganglion cell + inner plexiform layer (GC + IPL) thickness of each study group split by mean age and
gender. There was a statistically significant reduction in GCL + IPL between groups in female patients.
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and measured layers 500 μm away from the foveal center,
near to optical disc. The following layers were measured:
RNFL, ganglion cell layer (GCL), outer nuclear layer (ONL),
inner nuclear layer (INL), outer plexiform layer (OPL), inner
plexiform layer (IPL), and center foveal thickness (CS).
Analysis of variance with the Bonferroni post test was
conducted. Furthermore, reproducibility of subjectiveFigure 2 Boxplot shows mean retinal nerve fiber layer (RNFL) thickne
a statistically significant reduction in RNFL between groups in patients withmeasurements was analyzed, calculating the intraclass cor-
relation coefficient (ICC). A high ICC value indicates
small fluctuations between measurements from different
analyzers in the same individuals, indicating a high repro-
ducibility. However, a small ICC value shows large fluctua-
tions, featuring a low reproducibility. The maximum value
of the ICC is 1.0, while its minimum value is theoretically
zero. Values higher than 0.75 were considered acceptable.ss of each study group split by mean age and gender. There was
age below 59 years old and both gender.
Table 2 Thickness measures by software analysis
Mean thickenss by software analysis (μm)
Measure Control
(N = 28)




RT 284.07a ± 13.40 279.02 ± 14.26 271.46a ± 26.23
CS 260.61 ± 24.15 245.46 ± 24.36 254.68 ± 46.90
GCL + IPL 91.14bc ± 32.89 79.78b ± 7.36 73.96c ± 10.61
RNFL 45.93de ± 24.60 30.41d ± 3.46 29.78e ± 5.57
RT: Retinal thickness; CS: Central subfield of ETDRS grid; GCL + IPL: ganglion
cell layer and inner plexiform layer; RNFL: Retinal nerve fiber layer.
The letters a, b, c, d, eindicate significant difference between the groups
(a: p = 0.032, b: p = 0.039,c: p = 0.003,d: p < 0.001 , e: p < 0.001).
Figure 4 Boxplot shows mean ganglion cell + inner plexiform
layer (GC + IPL) thickness of each study group with macular cube
200×200. Mean CGL+ IPL and mean RNFL were thinner in the group
with DM with no DR when compared to control (P < 0.05). ANOVA
with Bonferroni post test indicated a statistically significant reduction
in GCL + IPL in DM with no DR compared to control (P = 0.039).
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and below 0.4, poor.
Data were collected and statistical analysis was performed
with SPSS (version 19; SPSS, Inc., Chicago, IL, USA). Para-
metric and non-parametric tests were conducted using ana-
lysis of variance (ANOVA) to compare retinal changes,
clinical data observed in the groups. For comparison of
means, a post hoc correction for multiple testing was
applied by the Bonferroni post test method. A multiple
linear regression model was used to determine the relation-
ship between inner retinal layer thickness and the duration
of DM, DR status, age, sex, and HbA1c in the diabetic
patients. The results were expressed as mean ± SD if the
variables were continuous, and as percentage if categorical.
Results
In total, 102 patients were included in this study, of
which 28 (27.4%) were classified into control group, 46
(45.0%) classified as diabetic patients with no DR and 28
(27.4%) classified as mild DR. The subjects included 42
men (41.2%) and 60 women (58.8%) with a mean age ofFigure 3 Boxplot shows mean central subfoveal (CS) thickness
of each study group measured with macular cube 200×200.
There was a slight reduction in diabetic groups compared to control
but without statistical significance (P > 0.05).58.67 (±10.7). There was a significant difference in age
(p = 0.015) and glycemia (0.015) between groups. The
demographic values are shown in Table 1. There was no
correlation between duration of DM, glycemia, glycosi-
lated haemoglobin to GCL or RNFL or RT. Figures 1 and 2
show the influence of gender and age on two outcome soft-
ware measures (GCL+ IPL and RNFL). The female group
showed a significant difference between groups in both mea-
sures (GCL+ IPL, p = 0.004; RNFL, p = 0.001). The male
group displayed a significant difference only in the GCL +
IPL measure (p = 0.011). The age group less than 59 years
showed a significant difference in RNFL (p = 0.002).Figure 5 Boxplot shows mean retinal nerve fiber layer (RNFL)
thickness of each study group with macular cube 200×200.
There was a statistically significant reduction in RNFL in DM without
DR or eyes with mild RD compared to the control group (P < 0.001).
Table 3 Standardized regression coefficients derived
from multiple linear regression









RT (R = 0.293, p = 0.012) Age −0.154 0.126
DR status −0.210 0.038
RNFL (R = 0.427, p < 0.001) Age −0.156 0.103
DR status −0.358 <0.001
GCL (R = 0.406, p < 0.001) Age −0.252 0.010
DR status −0.256 0.009
Regression coefficients are presented in standardized (z-score) form.
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analyzed. Thickness measurements of GCL+ IPL and RNFL
were significantly correlated with age (GCL, p = 0.001,
R = −0.315; RNFL, p = 0.010, R = −0.254). There was no
significant correlation between glycemia and the thicknesses,
nor between HbA1c and thicknesses. However, the correl-
ation between these clinical variables and thicknesses
showed a negative Pearson coefficient (R), indicating that
the higher the blood glucose or glycated hemoglobin, the
smaller thicknesses would be.Figure 6 Sectorized analysis of retinal thickness (RT) based on ETDRS m
IL: Inner left; II: Inner inferior; OS: Outer superior; OR: Outer right; OL: Outer leftAutomated analysis
In quantitative analysis with the Cirrus software, the
GCL+ IPL and RNFL were thinner in the group with
DM with no DR when compared to controls (p < 0.05). Fur-
thermore, GCL+ IPL and RNFL were even thinner in pa-
tients with DR (Table 2). ANOVA with Bonferroni post test
indicated a statistically significant reduction compared to
controls (p < 0.05) in the following retinal layers: RT in mild
DR group (p = 0.032); GCL+ IPL in DM with no DR group
(p = 0.039) and in mild DR group (p = 0.003); and RNFL in
DM without DR or eyes with mild RD (p < 0.001) (Figures 3,
4 and 5).
A multiple linear regression model was used to assess
the relationship between GCL thickness, RNFL thickness
and RT with variables with correlation (age and DR sta-
tus). In Table 3, standardized coefficients of the explana-
tory variables are presented. These variables show that
DR status is the most explanatory variable to thickness
reduction.
Sectored automated analysis
Using the ETDRS (Early Treatment Diabetic Retinopathy
Study) grid proposed subdivision, significance was found
in Macular thickness in the 8 grid (lower external) between
the mild DR group and controls (P = 0.032) (Figure 6).acular grid. Sectors: CS: central subfield; IS: Inner superior; IR: Inner right;
; OI: Outer inferior. The character *indicate significant reduction (p < 0.05).
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significant difference between the mild DR group and con-
trols in the following sectors: nasal inferior (P < 0.001),
nasal superior (P = 0.002), inferior (P < 0.011) and superior
(P = 0.034). In addition, significant differences in values
were observed between DM without DR and mild DR
groups in nasal inferior (P = 0.023) and inferior (P = 0.05)
sectors (Figure 7). Sectored analysis of RNFL showed sig-
nificant difference in the temporal superior sector between
the DM without DR group and controls (P = 0.004) and be-
tween the mild RD group and controls (P = 0.01) (Figure 8).
Subjective analysis
According to the subjective analysis of examiner 1, there
was a significant difference between the groups in GCL,
between the mild DR group and controls (P = 0.043),
and in CS between the DM with no DR group and con-
trols (P = 0.037). According to examiner 2, there were
significant changes between the groups in GCL, between
the DM with no DR group and controls (P < 0.001) and
between the mild DR group and controls (P < 0.001).
In analysis of reproducibility of measures between the
two observers using intraclass correlation (ICC), good
correlation in INL (0.77) and ONL (0.78) thickness mea-
surements was achieved. The correlation betweenFigure 7 Sectorized analysis of ganglion cell layer + inner plexiform la
Nasal Inferior; I: Inferior; TI: Temporal inferior; TS: Temporal superior. The chaexaminers in the measurements of GCL (0.64), IPL
(0.52), OPL (0.69) and fovea (0.72) was considered satis-
factory. RNFL measurement was considered have a poor
correlation (0.171).
Discussion
DR is the main cause of visual impairment and blindness
in the adult working-age population, and it has been pro-
posed to be primarily a retinal microvascular disorder
[10]. However, several recent publications have shown that
retinal neurodegeneration precedes clinically detectable
microvascular damage [1,2,4,11,12]. The hypothesis refer-
ring to the occurrence of neurodegeneration before vascu-
lar damage has been confirmed by electrophysiological
and psychophysical studies [13,14]. Recent studies in ani-
mals have revealed that diabetes causes the loss of differ-
ent types of retinal cells including ganglion cells, bipolar
cells, amacrine cells, horizontal cells, and eventually pho-
toreceptors [3,4,14,15]. Clinically, different authors have
reported a decrease in retinal thickness in diabetic eyes
with or without clinical signs of DR compared to normal
subjects [1,2,12,16-18]. Vujosevic and Midena as well as
Van Dijk et al. have shown a reduction in the inner retinal
thickness in the macula in diabetics with mild DR. Van Dijk
et al. speculates an initial GCL loss in the pericentral areasyer (GCL + IPL) thickness. Sectors: S: superior; NS: Nasal superior; NI:
racter * indicate significant reduction (p < 0.05).
Figure 8 Sectorized analysis of retinal nerve fiber layer (RNFL) thickness. Sectors: S: superior; NS: Nasal superior; NI: Nasal Inferior; I: Inferior;
TI: Temporal inferior; TS: Temporal superior. The character *indicate significant reduction (p < 0.05).
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addition, Vujosevic and Midena found outer retina may not
affect at early stages of DM and concluded that automatic
intraretinal layering by SD-OCT may be a useful tool to
diagnose and monitor early intraretinal changes in DR. In
our study, we evaluated whether diabetic patients with no
DR or mild DR had retinal changes measured by four pa-
rameters: GCL + IPL, RNFL, CS and RT.
The total macular thickness in diabetic eyes with no DR
and mild DR was examined in our paper using CS and RT,
and we found a significant reduction in eyes with mild DR
in RT (P = 0.032). These findings matched the results of
Biallosterski et al., who found that the mean RT in the
pericentral area was decreased in patients with minimal
DR compared to healthy controls. Verma et al. also found
reduction in foveal thickness in patients with DM and no
retinopathy compared to healthy individuals [6]. The re-
duction in RT later in patients with mild DR may mean
that thinning in one or more retinal layers may indeed
occur during disease evolution but requiring several years
to appear.
RNFL evaluation with SD-OCT has been a reliable par-
ameter in patients with glaucoma. Herein, analysis with Cir-
rus software disclosed reduction in RNFL both in patientswith no DR and those with mild DR. Similar findings of de-
creased RNFL has been noticed by van Dijk et al. in pa-
tients with mild DR [1]. Such outcomes ought to be
analyzed in conjunction with the results in the GCL + IPL,
since RNFL death occurs as axonal loss of GCL. In our
study, we demonstrated thinning of GCL + IPL both in pa-
tients with DM and no DR and those with mild DR. In
addition, there was a statistically significant difference in
GCL + IPL between the mild DR group and controls in the
superior, nasal superior, nasal inferior, and inferior sectors.
These results confirm previous studies both in animals and
humans, showing GCL damage as a primary finding in
patients with early DM [3,6,19-22]. Future studies should
investigate the clinical significance of these outcomes
and whether GCL may indeed be a particular cellular
target of DM.
Some of strengths of our study included examination of
both patients with DR or just DM and the objective analysis
with the OCT software in addition to a subjective retinal
measurement by two experimented examiners. On the other
hand, a limitation of our investigation was the poor intra-
class correlation between examiners in some retinal layers.
Besides that, the difference in age between groups was an-
other limitation. Despite this, a multiple linear regression
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thickness, RNFL thickness and RT with variables with cor-
relation (age and DR status), which showed that DR status
was the most explanatory variable. Other drawback of our
investigation was the uncertain onset of the DM, as type 2
DM patients may have the disease for some time before they
recognize the condition, but this fact would only underesti-
mate the findings.
Conclusions
Our paper reports early signs of neuroretinal changes by de-
tecting a significant thinning of different inner cell layers
and central retina in patients with early DR compared to
normal eyes. The investigation encountered thinning in
thickness of GCL and RFNL in patients with DM without
DR, which suggests neuroretinal changes before vascular
signs. Future studies should compare functional testing with
electrophysiology and microperimetry with OCT findings.
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